Armune BioScience Secures Contract for Apifiny with USA Managed Care Organization to Expand Access to Apifiny

KALAMAZOO, MI (PRWEB) January 27, 2016

Armune BioScience, an emerging leader in break-through cancer diagnostics, has secured a contractual agreement for Apifiny with USA Managed Care Organization, the largest, most comprehensive, privately-held preferred provider organization (PPO) in America. Under the terms of the agreement, Armune is established as a preferred provider, and its Apifiny test will be available to payers and over 6 million lives in the USA Managed Care Organization network. Armune continues to expand patient access to Apifiny through a growing number of insurance providers and reference laboratories.

Launched in the United States in April of 2015, Apifiny is the only cancer specific, non-PSA blood test designed to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny to help move beyond PSA based testing to assess prostate cancer risk.

"Securing a contract with USA Managed Care Organization is another example of the increased access Apifiny is gaining in the marketplace," said David A. Esposito, President and CEO of Armune BioScience. "Given the current concerns of PSA testing throughout the world, Apifiny is well positioned to offer clinicians additional information in the assessment of prostate cancer risk. We look forward to demonstrating to insurance providers how Apifiny will help to address our healthcare system's demand for improved outcomes at lower costs."

Apifiny was developed based on innovative research into the immune system's response to cancer conducted at the University of Michigan. Armune is currently expanding testing throughout the United States and preparing to launch Apifiny in several markets worldwide. Armune recently retained Mavericks Capital as the Company's advisor and investment bank.

About USA Managed Care Organization (http://www.usamco.com)
USA Managed Care Organization (USA MCO) is the largest, most comprehensive, privately-held Preferred Provider Organization in America. Through esteemed panels of preferred providers, ancillary products and specialty services covering the full continuum of care, USA offers innovative alternatives to traditional group health and workers' compensation medical benefits. With a distinct freedom of choice flexibility and a 100% user-friendly platform, USA affords sound solutions through a portfolio of integrated options that are uniquely client driven; focused on the seamless blend of quality care and cost containment.

About Mavericks Capital (http://www.maverickscap.com)
Mavericks Capital LLC and its licensed broker dealer, Mavericks Capital Securities LLC, specializes in advising companies on M&A, capital raises and strategic partnerships across the healthcare sector. With a senior team having deep medical perspectives, core scientific knowledge and proprietary analytics, we help construct and facilitate innovative and lucrative solutions for our clients. Our practice areas include therapeutics, devices, diagnostics, services and digital health.

About Armune BioScience (http://www.armune.com)
Armune BioScience, Inc. is a medical diagnostics company that develops and commercializes unique proprietary technology exclusively licensed from the University of Michigan for diagnostic and prognostic tests for prostate, lung and breast cancers. Armune was incorporated as a Delaware Corporation in 2008 with corporate headquarters in Kalamazoo, MI and a research and commercial laboratory in Ann Arbor, MI.

Read the full story at http://www.prweb.com/releases/2016/01/prweb13182828.htm